Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
2.000
+0.160 (8.70%)
At close: Dec 20, 2024, 4:00 PM
1.950
-0.050 (-2.50%)
After-hours: Dec 20, 2024, 5:51 PM EST
Immuneering Market Cap
Immuneering has a market cap or net worth of $62.10 million as of December 20, 2024. Its market cap has decreased by -74.03% in one year.
Market Cap
62.10M
Enterprise Value
15.68M
1-Year Change
-74.03%
Ranking
Category
Stock Price
$2.00
Market Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has decreased from $365.84M to $62.10M, a decrease of -83.03%. That is a compound annual growth rate of -40.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 62.10M | -71.13% |
| Dec 29, 2023 | 215.13M | 67.99% |
| Dec 30, 2022 | 128.06M | -69.91% |
| Dec 31, 2021 | 425.60M | 16.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scilex Holding Company | 58.00M |
| BioAtla | 57.53M |
| Modular Medical | 57.40M |
| Atara Biotherapeutics | 57.19M |
| Aadi Bioscience | 57.18M |
| CareCloud | 56.68M |
| Dyadic International | 56.37M |
| Boundless Bio | 56.19M |